May

    International Antitrust Developments in Health Care and Pharmaceuticals: October 2016 through April 2017

    12 PM EDT

    Join us for the fourth installment of the International Antitrust Developments Initiative, a series of semiannual programs on antitrust developments in health care and pharmaceuticals markets outside of the U.S. It has become paramount to approach antitrust issues from a global perspective in these markets; companies deal with many of the same core antitrust issues inside and outside of the U.S. but are often subject to varying standards and levels of enforcement. This new initiative aims to provide in-house and external antitrust practitioners with a solid understanding of key differences across jurisdictions, as well as an overview of major developments. The program on May 10, 2017 will cover developments from October 2016 through April 2017. 

    For information about our Committee membership, please contact Philip Nelson (nelson.p@ei.com) and Jeffrey Brennan (jbrennan@mwe.com). You can also visit our LinkedIn page:

    FREE:  Antitrust Section Members, Government, Non-profit Employees, Students
    $25 Other Non-Members
    Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25.   For this and all upcoming events visit http://ambar.org/atevents.
     
    CLE
    The ABA is not seeking CLE credit for this program.

    Audio Archive
    Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

     


     

    $25
    NON-MEMBERS
    $10
    MEMBERS
    $0
    SECTION MEMBERS
    Register Now *Additional discounts may apply at checkout

    Log In to view your rate

    International Antitrust Developments in Health Care and Pharmaceuticals: October 2016 through April 2017

    Event Details

    Format

    Teleconference

    Date

    May 10, 2017

    2017-05-10T12:00:00-04:00 2017-05-10T13:00:00-04:00 International Antitrust Developments in Health Care and Pharmaceuticals: October 2016 through April 2017

    Join us for the fourth installment of the International Antitrust Developments Initiative, a series of semiannual programs on antitrust developments in health care and pharmaceuticals markets outside of the U.S. It has become paramount to approach antitrust issues from a global perspective in these markets; companies deal with many of the same core antitrust issues inside and outside of the U.S. but are often subject to varying standards and levels of enforcement. This new initiative aims to provide in-house and external antitrust practitioners with a solid understanding of key differences across jurisdictions, as well as an overview of major developments. The program on May 10, 2017 will cover developments from October 2016 through April 2017. 

    For information about our Committee membership, please contact Philip Nelson (nelson.p@ei.com) and Jeffrey Brennan (jbrennan@mwe.com). You can also visit our LinkedIn page:

    FREE:  Antitrust Section Members, Government, Non-profit Employees, Students
    $25 Other Non-Members
    Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25.   For this and all upcoming events visit http://ambar.org/atevents.
     
    CLE
    The ABA is not seeking CLE credit for this program.

    Audio Archive
    Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

     


     

    Speakers

    Bernardo Cascao

    Barbosa Mussnich & Aragao Advogados

    Sponsors

    Health Care and Pharmaceuticals Committee

    Section of Antitrust Law

    Panelists

    Kaori Yamada

    Ninette Dodoo

    Simon Priddis

    Moderators

    Related Products

    Related On-Demand CLE